0 TSX News - January 22, 2019Spectral Announces Distribution Agreement for its Proprietary CRRT MachineTORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing […]Read More
0 TSX News - January 22, 2019Corvus Gold Continues Western Expansion of Mother Lode Deposit, Nevada, Returning 47 Metres @ 2.15 g/t Gold & 41 Metres @ 1.32 g/t Gold in Same HoleVANCOUVER, B.C., Jan. 22, 2019 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, OTCQX: CORVF) […]Read More
0 TSX Venture News - January 22, 2019Rio2 Limited Drills 192m @ 0.81 g/t Au and 124m @ 0.77 g/t Au at the Fenix Gold Project, ChileTORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; BVL: RIO) is pleased to […]Read More
0 TSX Venture News - January 22, 2019ALLEGIANT Options Out Three ProjectsVANCOUVER, British Columbia, Jan. 22, 2019 (GLOBE NEWSWIRE) — Allegiant Gold Ltd. (“ALLEGIANT”) (AUAU: TSX-V) (AUXXF: OTCQX) is pleased to […]Read More
0 TSX Venture News - January 22, 2019Wealth’s CEO to Speak at NobleCon XVVANCOUVER, British Columbia, Jan. 22, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: […]Read More
0 TSX Venture News - January 22, 2019K92 Mining Announces Record Production From Kainantu MineK92 announces record production of 16,844 ozs AuEq in Q4 and a record annual production of 47,237 ozs AuEq from […]Read More
0 NASDAQ Companies - January 22, 2019DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological DisordersMINNEAPOLIS, Jan. 22, 2019 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announces the publication of a paper titled “Human Tissue […]Read More
0 NASDAQ Companies - January 22, 2019Advanced Energy to Announce Fourth Quarter 2018 ResultsFORT COLLINS, Colo., Jan. 22, 2019 (GLOBE NEWSWIRE) — Advanced Energy Industries, Inc. (NASDAQ: AEIS), a global leader in innovative […]Read More
0 NYSE Companies - January 22, 2019Rexahn Presents Updated Preliminary Data on RX-3117 in Pancreatic Cancer at the 2019 ASCO GI SymposiumOverall Response Rate of 38% Observed in the First 24 Patients Who Had At Least One Scan on Treatment ROCKVILLE, […]Read More
0 NASDAQ Companies - January 22, 2019Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) DeficiencyLEXINGTON, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]Read More